MIM
STI

MetLife Investment Management’s SunTrust Banks, Inc. STI Stock Holding History

MetLife Investment Management’s Portfolio STI Stock Details STI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-120,811
Closed -$8.31M – 2366
2019
Q3 		$8.31M Sell
120,811
-1,524
-1% -$97.6K 0.09% 205
2019
Q2 		$7.69M Sell
122,335
-3,672
-3% -$231K 0.08% 217
2019
Q1 		$7.47M Sell
126,007
-2,479
-2% -$152K 0.08% 214
2018
Q4 		$6.48M Sell
128,486
-5,547
-4% -$332K 0.08% 221
2018
Q3 		$8.95M Sell
134,033
-2,801
-2% -$200K 0.09% 196
2018
Q2 		$9.03M Sell
136,834
-4,095
-3% -$278K 0.11% 171
2018
Q1 		$9.59M Sell
140,929
-6,359
-4% -$441K 0.11% 173
2017
Q4 		$9.51M Buy
+147,288
New +$8.99M 0.11% 175

Other funds holding STI

DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
RIA
Realta Investment Advisors Wilmington, Delaware $322M AUM 39.45% 1-Year Est. Return
SSB
Sandy Spring Bank Olney, Maryland $2.38B AUM 8.14% 1-Year Est. Return

MetLife Investment Management's STI Position: Q4 2019 in Review

MetLife Investment Management sold out of SunTrust Banks, Inc. (STI) in Q4 2019, closing a stake of 120,811 shares — an estimated $8.31M sold.

MetLife Investment Management first reported a position in STI in Q4 2017 and held it in 8 quarters. The position peaked at $9.59M in Q1 2018. 3 funds tracked by Wall St. Rank hold STI as of Q4 2019.

  • MetLife Investment Management reported no remaining SunTrust Banks, Inc. position as of Q4 2019 after selling out during the quarter.
  • MetLife Investment Management sold 120,811 SunTrust Banks, Inc. shares in Q4 2019, an estimated $8.31M.
  • MetLife Investment Management first reported a position in SunTrust Banks, Inc. in Q4 2017 and held it in 8 quarters.
  • MetLife Investment Management's SunTrust Banks, Inc. position peaked at $9.59M in Q1 2018.
  • 3 funds tracked by Wall St. Rank held SunTrust Banks, Inc. as of Q4 2019.

Based on MetLife Investment Management's 13F filing for Q4 2019, filed 14 Feb 2020.